Portfolio company
PBD Biotech
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops bacteriophage-based diagnostic tests to detect live mycobacteria infections in humans and animals for healthcare providers and the agriculture industry.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Rapid Myco
This company develops diagnostic tests for the rapid detection of mycobacterial infections in commercial livestock and humans.
Advanced Animal Diagnostics
This company develops on-farm diagnostic tests for livestock producers to detect infections and manage animal health.
FluoretiQ Limited
This company develops rapid point-of-care diagnostic tests that identify bacterial infections and antibiotic sensitivity for clinicians and veterinarians.
EcoPhage
This company develops bacteriophage-based biopesticides to manage bacterial diseases in crops for the agricultural industry.
DiagonalBio
This company develops molecular diagnostic systems for rapid, point-of-care pathogen detection in human healthcare, veterinary, and agricultural markets.
Phagos
The company develops AI-powered bacteriophage treatments to combat antibiotic-resistant bacterial diseases, primarily for the animal farming and healthcare sectors.
Phage therapy treatment
This company develops personalised bacteriophage cocktails and diagnostic susceptibility tests for patients suffering from multidrug-resistant bacterial infections.
PhageLab
PhageLab develops bacteriophage treatments to control bacterial pathogens in livestock and poultry production, reducing the industry's reliance on antibiotics.